SDShandra R. Day

Shandra R. Day

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shandra R. Day has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Society for Healthcare Epidemiology of America (SHEA) infectious diseases fellow infection prevention and control and healthcare epidemiology curriculum

    by Elise M. Martin, Catherine Cichon, Rebecca Choudhury, Shandra R. Day, Yasaman Fatemi, Vera P. Luther, Terri Stillwell, Abby Sung

    With the rapid expansion of the Infection Prevention Control/Healthcare Epidemiology (IPC/HE) fields over recent decades, the pivotal roles of IPC/HE in hospital regulation, quality improvement, patient safety, and healthcare finances have become increasingly apparent. Consequently, the demand for effective IPC/HE leaders has surged. 1,2 Training in IPC/HE is essential for all infectious diseases (ID) fellows (both adult and pediatric), including those planning a career in hospital epidemiology as well as those planning to focus on general ID, transplant, HIV, etc. ID fellows, however, have historically felt ill-prepared in IPC/HE. Joiner et al’s survey highlighted this gap, revealing that only half of respondents felt adequately trained in infection control, despite half of them participating in infection control in their practice. 3 IPC/HE fellow education is not currently standardized, and most IPC/HE training is led by individual mentors and healthcare facilities.


  • Open Access

    Outbreak of postpartum group a Streptococcus infections on a labor and delivery unit

    by Michael Haden, Christina Liscynesky, Nora Colburn, Justin Smyer, Kimberly Malcolm, Iahn Gonsenhauser, Kara M. Rood, Patrick Schneider, Michele Hardgrow, Preeti Pancholi, et al.

    A healthcare-associated group A Streptococcus outbreak involving six patients, four healthcare workers, and one household contact occurred in the labor and delivery unit of an academic medical center. Isolates were highly related by whole genome sequencing. Infection prevention measures, healthcare worker screening, and chemoprophylaxis of those colonized halted further transmission.


  • Open Access

    1285. Risk Factors for Infection Following Revision Hip and Knee Arthroplasty

    by Joseph DeBiase, Ryan Carroll, Nora Colburn, Shandra R Day

    Patients undergoing revision total hip (THA) and knee (TKA) arthroplasties are at increased risk for surgical site infections (SSI) with prior infection representing a common indication for revision. Our aim was to evaluate patient characteristics and risk factors in patients with THA and TKA infection following revision arthroplasty. A single center retrospective review of patients with THA or TKA SSIs from 01/01/2017 to 11/01/2022 was performed utilizing National Healthcare Safety Network (NHSN) definitions and surgical revision codes. Index surgery was defined as the THA or TKA to which the SSI was attributed per NHSN guidelines. Patients meeting NHSN PATOS (present at time of surgery) definition were excluded. Pertinent demographics data, surgical histories and microbiology were collected and the determination of new vs. persistent infection was made based on microbiologic data. Over half of patients that developed revision THA/TKA SSI had a prior infection but less than 15% had a persistent infection. Most patients had multiple prior surgeries which may contribute to longer operative times and delayed wound healing. S. aureus was the most common pathogen identified but many cases involved less typical SSI pathogens. These results highlight the importance of focusing on patient specific risk factors, surgical infection prevention strategies and wound care, rather than additional pathogen specific antibiotics. While more study is needed to delineate SSI risk factors following revision arthroplasty, our study highlights the multitude of potential factors involved in these highly morbid infections. All Authors: No reported disclosures

  • Open Access

    Successful model of shared medical directorship in Hospital Epidemiology

    by Christina Liscynesky, Shandra R. Day, Nora E. Colburn, Susan L. Koletar

    To the Editor-Healthcare Epidemiology programs are a requirement of the Joint Commission and the Centers for Medicare & Medicaid Services. 1,2 The nationally recommended ratio for infection preventionists (IPs) is 1 IP per 69 inpatient beds. 3 The amount of necessary physician support is less clear. Should it be delineated based on inpatient bed number, ambulatory clinic numbers, or geographic area? Traditionally, a single medical director oversees the department of Hospital epidemiology, and depending on the size and needs of the institution, associate medical directors (AMDs) may be needed as well. We report our successes in challenging that classic framework with a co-medical-director model.

  • Open Access

    Describing the monthly variability of hospital-onset Clostridioides difficile during early coronavirus disease 2019 (COVID-19) using electronic health record data

    by Kaiting Lang, T. J. Atchison, Priti Singh, David M. Kline, James B. Odei, Jennifer L. Martin, Justin F. Smyer, Shandra R. Day, Courtney L. Hebert

    Objective: To assess the relative risk of hospital-onset Clostridioides difficile (HO-CDI) during each month of the early coronavirus disease 2019 (COVID-19) pandemic and to compare it with historical expectation based on patient characteristics.Design: This study used a retrospective cohort design. We collected secondary data from the institution’s electronic health record (EHR).Setting: The Ohio State University Wexner Medical Center, Ohio, a large tertiary healthcare system in the Midwest.Patients or participants: All adult patients admitted to the inpatient setting between January 2018 and May 2021 were eligible for the study. Prisoners, children, individuals presenting with Clostridioides difficile on admission, and patients with <4 days of inpatient stay were excluded from the study.Results: After controlling for patient characteristics, the observed numbers of HO-CDI cases were not significantly different than expected. However, during 3 months of the pandemic period, the observed numbers of cases were significantly different from what would be expected based on patient characteristics. Of these 3 months, 2 months had more cases than expected and 1 month had fewer.Conclusions: Variations in HO-CDI incidence seemed to trend with COVID-19 incidence but were not fully explained by our case mix. Other factors contributing to the variability in HO-CDI incidence beyond listed patient characteristics need to be explored.


  • Open Access

    Whole-genome sequencing of carbapenem-resistant Enterobacterales isolates and evaluation of hospital-acquired infections

    by Leama Ajaka, Shandra Day, Christina Liscynesky, Nora Colburn, Christine Sun, Michael Sovic, Preeti Pancholi, Joan-Miquel Balada-Llasat, Heather Smith, Shashanka Murthy

    Background: Multidrug-resistant organisms (MDROs) are increasingly implicated in nosocomial outbreaks worldwide. We evaluated whole-genome sequencing (WGS) as an adjunctive epidemiological tool to identify infection clusters and MDRO transmission in the healthcare setting. Methods: Clinical isolates of carbapenem-resistant Enterobacterales (CRE) from July 1, 2021, to June 30, 2022, underwent Illumina WGS. Assembled genomes were taxonomically classified with GTDB-Tk software and were typed using multilocus sequence typing (MLST). Average nucleotide identity (ANI) was calculated between genomes. Numbers of differences among core single-nucleotide polymorphisms (SNPs) were calculated for pairs within taxonomic groups, and the data were evaluated in the context of patient dates and locations of care obtained from the electronic medical record. Results: In total, 39 CRE isolates underwent WGS (Fig. 1). Klebsiella pneumoniae represented the largest number of isolates (n = 18). Using MLST, 2 distinct groups of K. pneumoniae were identified (ST307 and ST258) with 5 and 4 isolates, respectively (Fig. 2). Within ST307, SNP differences ranged between 8 and 115. 3 isolates (CRE8, CRE10, and CRE12) were collected within 4 weeks of each other and had ≤26 pairwise SNP differences. Notably, CRE8 and CRE10 were located on the same unit at the same time and used the same MRI scanner on the same day. CRE35 had >95 SNP differences and was admitted 8 months prior to others in ST307 but had surgery in the same OR as CRE8. Within ST258, pairwise comparison of samples revealed 139–588 SNP differences. CRE21, CRE31, and CRE33 had SNP differences of ≤150. These patients were in the same hospital room (CRE33 and CRE21) and unit (CRE31 and CRE33), but they did not overlap temporally. CRE37 had >580 SNP differences, with no overlap in hospitalization dates or locations with other patients. Conclusions: Two closely related K. pneumoniae isolate populations were identified using WGS. Strong temporal and spatial commonalities were identified among isolates with few SNP differences. Isolate pairs with intermediate SNP differences shared spatial commonalities, suggesting possible indirect transmission between patients. No common exposures were identified for pairs with large numbers of SNP differences. WGS is an evolving tool to detect outbreak clonal populations of MDRO not identified through traditional epidemiologic techniques. WGS can provide insight into transmission patterns and the role of environmental contamination in propagating these nosocomial infections. More studies are needed to define the role and clinical significance of isolates with intermediate SNP differences in transmission of these pathogens between hosts and the healthcare environment. Disclosures: None

  • Open Access

    Experiential learning and mentorship as the foundation of clinical epidemiology training during infectious diseases fellowship: Response to “Training infectious diseases fellows for a new era of hospital epidemiology”

    by Shandra R. Day, Mohammad Mahdee Sobhanie, Nora E. Colburn, Christina Liscynesky

    A specific, clinical-epidemiology, month-long rotation for all infectious disease fellows as well as a 1-year subspecialty track provides education in clinical epidemiology during infectious disease fellowship training. We describe the educational process created at our institution to provide this training.